Ideaya Biosciences Inc (IDYA) stock news · rev $218.7M
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
This IDYA news page leads with what Ideaya Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for IDYA yet. We will not pad this page with generic market recap.
Latest reported IDYA revenue for 2025-12-31 was $218.7M. Net income was -$113.7M. Revenue was up 3024.4% from 2024-12-31 to 2025-12-31. IDYA currently screens at market cap $2.96B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IDYA stock page; for the tape open the quote page.
IDYA stock news FAQ
What are IDYA's latest revenue and net income?
Latest cached Ideaya Biosciences Inc (IDYA) revenue for Dec 31, 2025 was $218.7M. Net income was -$113.7M. Statements: https://lician.com/financials/idya
How did IDYA revenue change from the prior cached period?
Cached Ideaya Biosciences Inc (IDYA) revenue was up 3024.4% from $7.0M (Dec 31, 2024) to $218.7M (Dec 31, 2025). Statements: https://lician.com/financials/idya
What is IDYA's market cap?
Ideaya Biosciences Inc (IDYA) market cap is $2.96B on the latest cached fundamentals snapshot.
What kind of company is IDYA?
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Where is IDYA stock news listed?
Cached stock news for Ideaya Biosciences Inc (IDYA) is listed at https://lician.com/news/idya. Filings: https://lician.com/sec/idya
Not investment advice.